RUVBL2 and acute myeloid leukemia: A recent paper shows that bioinformatic analysis identifies that PLA2G4A has physical interactions with several oncogenic proteins (such as RUVBL2, CAP1, STAT3, and MYCBP) in AML, resulting in multiple effects on the malignant phenotype of AML cells (41).